(HealthDay News) – Evidence suggests that transdermal testosterone patches may relieve symptoms of hypoactive sexual desire disorder (HSDD) in postmenopausal women, according to a review published ...
Cleveland, Ohio - August 14, 2007 – Novel research published in the current issue of The Journal of Sexual Medicine supports the claim that women with hypoactive sexual desire disorder or HSDD ...
Hypogonadal men found to have greater clinical improvement with transdermal delivery. TORONTO—Smooth and prolonged release of testosterone by transdermal delivery (Testopatch) translates into greater ...
Transdermal exogenous testosterone improves libido in postmenopausal women receiving estrogen therapy. Davis et al. have now demonstrated that 300 µg of testosterone a day, administered via skin ...
FDA-approved transdermal delivery systems for testosterone include patches, gels, and buccal tablets. A more convenient method to deliver testosterone through the skin is needed, however, as problems ...
Phase III double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea during pelvic radiation therapy: Results of North Central Cancer Treatment Group protocol N00CA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results